openPR Logo
Press release

CRISPR And Cas Gene Market Analysis 2024 -2033 : Forecasted Market Size, Top Segments, And Largest Region | F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporatio

03-19-2024 05:54 AM CET | Health & Medicine

Press release from: The Business Research Company

CRISPR And Cas Gene Global Market Report 2024

CRISPR And Cas Gene Global Market Report 2024

"The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.

The Business Research Company presents an extensive market research report on the CRISPR And Cas Gene Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:

The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence.

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing.

Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp

Key Market Players:
Major companies operating in the crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

Market Drivers:
A growing focus on personalized therapy is expected to propel the growth of the CRISPR and Cas gene markets going forward. Personalized therapy refers to a medical model that uses an individual's genetic profile to guide decisions made concerning the diagnosis, treatment, and prevention of disease. CRISPR and the Cas gene, particularly Cas9, are used in personalized medicine, enabling precise modifications to an individual's genetic material and holding promise for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the rising demand for personalized therapy will drive the growth of the CRISPR and Cas gene markets.

Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

The crispr and cas gene market covered in this report is segmented -
1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CRISPR And Cas Gene Market Analysis 2024 -2033 : Forecasted Market Size, Top Segments, And Largest Region | F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporatio here

News-ID: 3435036 • Views:

More Releases from The Business Research Company

Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody Market Landscape
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody
Top Players and Competitive Dynamics in the Menopause Supplement Market
Top Players and Competitive Dynamics in the Menopause Supplement Market
The menopause supplement market is set for significant expansion in the coming years, driven by evolving healthcare demands and growing awareness of women's wellness. As more individuals seek tailored health solutions, the market is responding with innovative products and services designed to support women during menopause and beyond. Below, we explore the market size, influential players, and emerging trends shaping this industry's future. Expected Growth Trajectory of the Menopause Supplement Market The
In-Depth Examination of Segments, Industry Developments, and Key Players in the Liquid Carbon Dioxide Storage Tanks Market
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The market for liquid carbon dioxide storage tanks is set for strong expansion in the coming years, supported by rising sustainability priorities and steady technological advancements across multiple industries. A closer look at the market size, major players, evolving trends, and detailed segmentation provides a clear understanding of the current dynamics and future potential. Projected Growth and Market Size of Liquid Carbon Dioxide Storage Tanks The liquid carbon dioxide storage tanks market
Leading Companies Fueling Innovation and Growth in the Isotype Control Antibody Market
Leading Companies Fueling Innovation and Growth in the Isotype Control Antibody …
The isotype control antibody market is set for significant expansion in the coming years, driven by advancements in medical research and technology. As laboratories and pharmaceutical companies increasingly adopt precision medicine, this sector is poised for rapid growth, reflecting broader trends in healthcare and biotechnology. Anticipated Market Growth and Size for Isotype Control Antibodies The market for isotype control antibodies is projected to reach $189.82 billion by 2029, growing at a robust

All 5 Releases


More Releases for Cas

Top Factor Driving Cas Nuclease Market Growth in 2025: Increasing Biotech Invest …
How Big Is the Cas Nuclease Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a quick escalation in the size of the cas nuclease market. The market valuation is projected to increase from $3.27 billion in 2024 to $3.89 billion in 2025, while maintaining a compound annual growth rate (CAGR) of 19.2%. This significant growth during the historical period can be traced
Altimedia Achieves Widevine CAS 3PL Partnership
Image: https://www.abnewswire.com/uploads/1671b7044637885642f07dbf55abb228.jpg Global digital media total solutions company Altimedia named a certified 3PL (Third Party Lab) partner for its Widevine CAS solution, AltiProtect-WCAS. This partnership underscores Altimedia's reliability and technical expertise in the global digital content protection solutions market. AltiProtect-WCAS, originated from the source technology of Widevine, is a conditional access solution that helps PayTV service providers prevent illegal copying and unauthorized access. With this new 3PL partnership, it's verified Altimedia offers
Visit CAS DataLoggers at WEFTEC 2022
Ernest N. Morial Convention Center, October 8 - 12, New Orleans, LA CAS DataLoggers is proud to announce that we will be exhibiting at the WEFTEC 2022 Conference! Hosted at the Morial Convention Center in New Orleans, LA on October 8-12, WEFTEC 2022 will bring together water professionals from around the world in person and virtually! This year, CAS DataLoggers President Peter Martin is attending along with CAS DataLoggers Engineering Manager
Visit CAS DataLoggers at Pittcon 2020
The World's Largest Lab Expo, March 3rd-5th in Chicago CAS DataLoggers is proud to announce that we will be exhibiting along with TandD US, LLC at Pittcon 2020! Pittcon is the world's leading annual conference and exposition on laboratory science. Hosted in Chicago, IL at McCormick Place on March 3rd-5th, Pittcon 2020 will draw a large crowd of attendees from industry, academia, and government from over 90 countries! This year, CAS
Visit CAS DataLoggers at AHR 2020
The World’s Largest HVAC event is about to get underway—the annual AHR 2020 Expo is returning to Orlando, FL on Feb 3-5th. CAS DataLoggers Sales Mgr. Peter Martin is proud to attend along with Japan’s #1 datalogger manufacturer—T&D! Come visit us at Booth #7490 to see our cutting-edge HVAC solutions for performance validation, energy audits, and more! With prices starting at just $109, T&D products give businesses and organizations an affordable
CRISPR & CRISPR-associated (Cas) Genes Market to 2027 - Global Analysis and Fore …
CRISPR and CRISPR-Associated (Cas) Genes is a genome editing tool that enables the researchers to make changes in the DNA. CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. In recent years the CRISPR and CRISPR-Associated (Cas) Genes has gained lot of popularity as it offers it is cheaper, faster, accurate, and more efficient genome editing methods. The CRISPR and CRISPR-associated (Cas) Genes market is anticipated to